Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

ObjectiveThis study aimed to evaluate the risk of adverse events associated with chloroquine (CQ) and hydroxychloroquine (HCQ) in patients with systemic lupus erythematosus (SLE), using data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).MethodsDisproportionality a...

Cijeli opis

Bibliografski detalji

Glavni autori:	Xiang Li, Si-Qi Zhang, Ke-Rui Wang, Shi-Nan Wu, Meng-Yuan Wang, Cui-Ting Chen, Nuo Dong
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-06-01
Serija:	Frontiers in Pharmacology
Teme:	cloroquine hydroxychloroquine ocular adverse events FAERS systemic lupus erythematosus
Online pristup:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1498814/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!